The effects of black cohosh therapies on lipids, fibrinogen, glucose and insulin

Maturitas

Volumn 57, Issue 2, 2007, Pages 195-204

  Spangler, Leslie ^a   Newton, Katherine M ^a,b   Grothaus, Louis C ^a   Reed, Susan D ^a,b,c,d   Ehrlich, Kelly ^a   LaCroix, Andrea Z ^a,b,c  

^a CENTER FOR HEALTH STUDIES   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Black cohosh; Cimicifuga racemosa; Fibrinogen; Glucose; Insulin; Lipid

Indexed keywords

CHOLESTEROL; CIMICIFUGA RACEMOSA EXTRACT; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; MEDROXYPROGESTERONE ACETATE; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; CIMICIFUGA RACEMOSA; CONTROLLED STUDY; COUNSELING; DEMOGRAPHY; DIET; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VASOMOTOR DISORDER;

BLOOD GLUCOSE; CIMICIFUGA; DOUBLE-BLIND METHOD; ESTROGEN REPLACEMENT THERAPY; FEMALE; FIBRINOGEN; HOT FLASHES; HUMANS; INSULIN; LIPIDS; MENOPAUSE; MIDDLE AGED; PHYTOESTROGENS; PHYTOTHERAPY; TREATMENT OUTCOME;

CIMICIFUGA DAHURICA; CIMICIFUGA RACEMOSA; EQUIDAE;

EID: 34248649851     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.01.002     Document Type: Article

References (39)

1. Newton K.M., Buist D.S., Keenan N.L., Anderson L.A., and LaCroix A.Z. Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol 100 (2002) 18-25
2. Kang H.J., Ansbacher R., and Hammoud M.M. Use of alternative and complementary medicine in menopause. Int J Gynaecol Obstet 79 (2002) 195-207
3. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
4. Shumaker S.A., Legault C., Rapp S.R., et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003) 2651-2662
5. Newton K.M., Reed S.D., Grothaus L., et al. The Herbal Alternatives for Menopause (HALT) Study: background and study design. Maturitas 52 (2005) 134-146
6. Cimicifuga racemosa. Monograph. Altern Med Rev 2003;8:186-9.
7. Ness J., Aronow W.S., and Beck G. Menopausal symptoms after cessation of hormone replacement therapy. Maturitas 53 (2006) 356-361
8. Blumenthal M. Herb market levels after 5 years of boom. HerbalGram 47 (1999) 64
9. Blumenthal M. Garlic is top-selling herb; herb combinations see increase. HerbalGram 66 (2005) 63
10. Kelly J.P., Kaufman D.W., Rosenberg L., Kelley K., Cooper S.G., and Mitchell A.A. Use of postmenopausal hormone therapy since the Women's Health Initiative findings. Pharmacoepidemiol Drug Saf 14 (2005) 837-842
11. Jarry H., Metten M., Spengler B., Christoffel V., and Wuttke W. In vitro effects of the Cimicifuga racemosa extract BNO 1055. Maturitas 44 Suppl 1 (2003) S31-S38
12. Jiang B., Kronenberg F., Nuntanakorn P., Qiu M.H., and Kennelly E.J. Evaluation of the botanical authenticity and phytochemical profile of black cohosh products by high-performance liquid chromatography with selected ion monitoring liquid chromatography-mass spectrometry. J Agric Food Chem 54 (2006) 3242-3253
13. Li W., Sun Y., Liang W., Fitzloff J.F., and van Breemen R.B. Identification of caffeic acid derivatives in Actea racemosa (Cimicifuga racemosa, black cohosh) by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 17 (2003) 978-982
14. Mahady G.B. Black cohosh (Actaea/Cimicifuga racemosa): review of the clinical data for safety and efficacy in menopausal symptoms. Treat Endocrinol 4 (2005) 177-184
15. Piersen C.E. Phytoestrogens in botanical dietary supplements: implications for cancer. Integr Cancer Ther 2 (2003) 120-138
16. Mahady G.B. Is black cohosh estrogenic?. Nutr Rev 61 (2003) 183-186
17. Borrelli F., Izzo A.A., and Ernst E. Pharmacological effects of Cimicifuga racemosa. Life Sci 73 (2003) 1215-1229
18. Gustafsson J.A. What pharmacologists can learn from recent advances in estrogen signalling. Trends Pharmacol Sci 24 (2003) 479-485
19. Sheehan D.M. Herbal medicines, phytoestrogens and toxicity: risk:benefit considerations. Proc Soc Exp Biol Med 217 (1998) 379-385
20. Chlebowski R.T., Hendrix S.L., Langer R.D., et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA 289 (2003) 3243-3253
21. Messina M., Nagata C., and Wu A.H. Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 55 (2006) 1-12
22. National Cholesterol Education Program. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. NIH Publication No. 02-5215. Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf [accessed April 14, 2006].
23. Fred Hutchinson Cancer Research Center. Nutrition Assessment Shared Resource (NASR) Food Frequency Questionnaires (FFQ). Available at: http://ffq.fhcrc.org [accessed January 1, 2006].
24. Manson J.E., Hsia J., Johnson K.C., et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349 (2003) 523-534
25. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) Trial. JAMA 273 (1995) 199-208
26. Wuttke W., Gorkow C., and Seidlova-Wuttke D. Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double blind, placebo-controlled, and conjugated estrogens-controlled study. Menopause 13 (2006) 185-196
27. Raus K., Brucker C., Gorkow C., and Wuttke W. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055. Menopause 13 (2006) 678-691
28. Nappi R.E., Malavasi B., Brundu B., and Facchinetti F. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol 20 (2005) 30-35
29. Hirschberg A.L., Edlund M., Svane G., Azavedo E., Skoog L., and von Schoultz B. An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women. Menopause (2006)
30. Williamson E.M. Synergy and other interactions in phytomedicines. Phytomedicine 8 (2001) 401-409
31. Balk E, Chung M, Chew P, et al. Effects of Soy on Health Outcomes, Evidence Report/Technology Assessment No. 126. AHRQ Publication No. 05-E024-2. Rockville, MD: Agency for Healthcare Research and Quality; 2005.
32. Espeland M.A., Hogan P.E., Fineberg S.E., et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Postmenopausal estrogen/progestin interventions. Diabetes Care 21 (1998) 1589-1595
33. Lobo R.A., Bush T., Carr B.R., and Pickar J.H. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism. Fertil Steril 76 (2001) 13-24
34. Dent S.B., Peterson C.T., Brace L.D., et al. Soy protein intake by perimenopausal women does not affect circulating lipids and lipoproteins or coagulation and fibrinolytic factors. J Nutr 131 (2001) 2280-2287
35. Sanders T.A., Dean T.S., Grainger D., Miller G.J., and Wiseman H. Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor beta(1) concentrations and hemostatic risk factors for coronary heart disease in healthy subjects. Am J Clin Nutr 76 (2002) 373-377
36. Acs N., Vajo Z., Miklos Z., et al. The effects of postmenopausal hormone replacement therapy on hemostatic variables: a meta-analysis of 46 studies. Gynecol Endocrinol 16 (2002) 335-346
37. Wuttke W., Seidlova-Wuttke D., and Gorkow C. The Cimicifuga preparation BNO 1055 versus conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 44 Suppl 1 (2003) S67-S77
38. Osmers R., Friede M., Liske E., Schnitker J., Freudenstein J., and Henneicke-von Zepelin H.H. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 105 (2005) 1074-1083
39. Liske E., Hanggi W., Henneicke-von Zepelin H.H., Boblitz N., Wustenberg P., and Rahlfs V.W. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosa rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend Based Med 11 (2002) 163-174